-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VY34GZqWSpnSQ7e9HVXNRDeY1Bs5+rG3+BQqsWIaEjdRMzhJfk631av4cbrCk4PL 7qXDIhvAWN5MxVS1w6GF0w== 0001285101-06-000002.txt : 20060421 0001285101-06-000002.hdr.sgml : 20060421 20060421125231 ACCESSION NUMBER: 0001285101-06-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060421 FILED AS OF DATE: 20060421 DATE AS OF CHANGE: 20060421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHANNON COLIN CENTRAL INDEX KEY: 0001285101 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 06771894 BUSINESS ADDRESS: BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST. CITY: WILMINGTON STATE: NC ZIP: 28412 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-04-21 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001285101 SHANNON COLIN 216 GATEFIELD DRIVE WILMINGTON NC 28412 0 1 0 0 EVP, Global Clinical Ops Stock Options (to buy) 14.22 2006-02-13 2013-02-12 Common Stock 9000 9000 D Stock Options (to buy) 15.43 2006-03-04 2014-03-03 Common Stock 19334 19334 D Stock Options (to buy) 17.15 2006-07-16 2014-07-15 Common Stock 40000 40000 D Stock Options (to buy) 21.19 2005-11-16 2014-11-15 Common Stock 130000 130000 D Stock Options (to buy) 34.62 2007-02-22 2016-02-21 Common Stock 40000 40000 D 9,667 options are vested and exercisable as of 3/4/06; an additional 9,667 become vested and exercisable on 3/4/07. 20,000 options are vested and execisable as of 7/16/06; an additional 20,000 become vested and exercisable on 7/16/07. This option was awarded on 11/16/04 and vests in four equal installments on 11/16/05, 11/16/06, 11/16/07 and 11/16/08. This option was awarded on 2/22/06 and vests in three equal installments on 2/22/07, 2/22/08 and 2/22/09. This report is being filed solely for informational purposes to reflect the Company's two-for-one stock split which was completed in February 2006. Lisa C. Noecker attorney-in-fact for Colin Shannon 2006-04-21 -----END PRIVACY-ENHANCED MESSAGE-----